Site logo
Sticky header logo
Mobile logo
  • About the project
    • The project
    • Work Packages
    • Who we are
      • Consortium Partners
      • Consortium Members
  • Progress
  • Project news
  • Resources
  • EnglishEnglish
    • FrançaisFrançais
    • EspañolEspañol
    • PortuguêsPortuguês

Resources

Dr Clara Menéndez – ISGlobal

Dr. Francisco Saúte – Mozambique, CISM

Dr. Augustin Fombah – Ministry of Health Sierra Leone and ISGlobal

Key publications on IPTi

 

  1. WHO. World malaria report. WHO 2019; Available at

https://www.who.int/publications/i/item/9789241565721

 

  1. WHO. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for

Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. World Health Organization. 2012; Available at :

https://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf

 

  1. WHO. WHO Policy recommendation on intermittent preventive treatment during

infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. World Health Organization. 2010; Available at :

https://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf?ua=1

 

  1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al. Efficacy

and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in

African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet (London, England). 2009;374(9700):1533-42. Available at:

https://pubmed.ncbi.nlm.nih.gov/19765816/

 

  1. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, et al. The cost-effectiveness

of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PloS one.

2010;5(6):e10313. Available at:

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010313

 

  1. Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in

infants. The Cochrane database of systematic reviews. 2019;12(12):Cd011525. Available at: https://pubmed.ncbi.nlm.nih.gov/31792925/

 

  1. WHO. GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016–2030. World Health

Organization. 2015. Available at : https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf

 

  1. Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, et al. Molecular

markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment

for malaria in Mozambican infants. The Journal of infectious diseases. 2008;197(12):1737-42. Available at:

https://academic.oup.com/jid/article/197/12/1737/867000

 

  1. Alexander N, Sutherland C, Roper C, Cissé B, Schellenberg D. Modelling the impact of

intermittent preventive treatment for malaria on selection pressure for drug resistance.

Malaria journal. 2007;6:9. Available at:

https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-6-9

 

  1. O’Meara WP, Smith DL, McKenzie FE. Potential impact of intermittent preventive

treatment (IPT) on spread of drug-resistant malaria. PLoS medicine. 2006;3(5):e141. Available at:

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030141

 

  1. Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, et al. Association of

transmission intensity and age with clinical manifestations and case fatality of severe

Plasmodium falciparum malaria. Jama. 2005;293(12):1461-70. Available at: https://pubmed.ncbi.nlm.nih.gov/15784869/

 

  1. Roca-Feltrer A, Carneiro I, Smith L, Schellenberg JR, Greenwood B, Schellenberg D. The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings. Malaria journal. 2010;9:282. Available at: https://pubmed.ncbi.nlm.nih.gov/20939931/

 

  1. Crawley J, Sismanidis C, Goodman T, Milligan P. Effect of intermittent preventive

treatment for malaria during infancy on serological responses to measles and other vaccines

used in the Expanded Programme on Immunization: results from five randomised controlled

trials. Lancet (London, England). 2012;380(9846):1001-10. Available at: https://pubmed.ncbi.nlm.nih.gov/22850358/

 

  1. Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-Resistant

Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015. Emerging infectious diseases. 2018;24(1):40-8. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749434/

 

  1. WHO. Reported estimates of MCV1 coverage. 2020. Available at :

https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragemcv1.html

 

  1. Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, et al. Cost-

effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bulletin of the World Health Organization. 2009;87(2):123-9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636201/

 

  1. UNICEF. Levels and Trends in Child Mortality. 2019; Available at

http://documents1.worldbank.org/curated/en/105841568905930695/pdf/Levels-and-Trends-in-Child-Mortality-Report-2019.pdf

Authors
  • All
  • All

SUPPORTED

This project is part of the EDCTP2 programme supported by the European Union
 

M

  • About the project
    • The project
    • Work Packages
    • Who we are
      • Consortium Partners
      • Consortium Members
  • Progress
  • Project news
  • Resources
  • EnglishEnglish
    • FrançaisFrançais
    • EspañolEspañol
    • PortuguêsPortuguês
  • Privacy Policy
  • Legal Notice
  • Cookies Policy
div#stuning-header .dfd-stuning-header-bg-container {background-image: url(https://multiplyipti.net/wp-content/uploads/2021/10/IMG-20210721-WA0013.jpg);background-color: transparent;background-size: cover;background-position: center center;background-attachment: initial;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 400px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
_GRECAPTCHA5 months 27 daysThis cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
pll_language1 yearThe pll _language cookie is used by Polylang to remember the language selected by the user when returning to the website, and also to get the language information when not available in another way.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_V7X49RQ9M42 yearsThis cookie is installed by Google Analytics.
_gat_gtag_UA_62695359_131 minuteSet by Google to distinguish users.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
vuid2 yearsVimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo